Result page for
Testosterone propionate:
Testosterone propionate
![144](./images/144.png)
General information:
Withdrawal information:
Withdrawn due to drug safety reasons: | No |
First approved: |
1974 |
First withdrawn: |
1982 |
Side-effects:
Total reported cases (submitted by medical professionals)
with Testosterone propionate as primary suspect: |
3 |
Reported final outcomes:
Hospitalization (initial or prolonged): |
2 |
Life-Threatening condition: |
1 |
Intervention required to
prevent permanent impairment/damage: |
1 |
Death: |
1 |
Reported side-effects:
Side-effect |
Case number |
VENTRICULAR TACHYCARDIA | 1 |
VENTRICULAR HYPOKINESIA | 1 |
VENTRICULAR HYPERTROPHY | 1 |
RESPIRATORY FAILURE | 1 |
POST PROCEDURAL COMPLICATION | 1 |
PENIS DISORDER | 1 |
Injection site swelling | 1 |
Injection site pain | 1 |
DRUG WITHDRAWAL SYNDROME | 1 |
DERMAL CYST | 1 |
CARDIAC ARREST | 1 |
AORTIC STENOSIS | 1 |
ANAESTHETIC COMPLICATION CARDIAC | 1 |
Filtered ChEMBL targets:
Target UniProtKB ID |
Activity in nm |
Target Name |
Target gene |
P02545 |
7.9 |
Prelamin-A/C |
LMNA_HUMAN |
P10275 |
0.25 |
Androgen receptor |
ANDR_HUMAN |
Toxicity information:
Toxicity class: |
4 |
Toxicity type: |
N/A |
LD50: |
1000 mg/kg |
External links: